Wednesday, November 25, 2009
Almost time to say goodbye...
Wednesday, November 18, 2009
First time I have set foot on campus in a while
Tuesday, November 10, 2009
Big Brother
Wednesday, November 4, 2009
What if I was diabetic?


Wednesday, October 28, 2009
A Fine Line
Wednesday, October 21, 2009
Just to follow suit
I guess it is just part of the culture that we live in. I remember when I was searching for the videos that we neeed to watch online, I found a channel that was broadcasting the "Common Threads" movie. I quickly realized that the channel was all centered around the gay lifestyle and their programming reflected many different facets of it such as the reality of HIV in their population and what the community was doing about it. Because HIV affects all people regardless of their background, it would be nice to see if the mainstream culture could take a lesson and begin to become pro-active with dealing with such major issues as HIV. Also as a side issue, I wonder if we will hear anything in the news about South Africa and their AIDS situation as the next World Cup moves closer to the time. I think if we did it would be out of the regular ignorance that we see in our society still today. That's about all for now, hope you found this just a little bit interesting.....
DID YOU KNOW?
In light of our QOTW I have found some information regarding current HIV medications and renal transplants. With the discovery of the highly active antiretroviral therapy that was made to be available to people in 1996, there have been many more opportunities for people who are infected with HIV to actually have surgeries that can benefit them, when in the past it would be viewed as a waste (Tebas, 2009). I wanted to make sure that the whole article was brought through to here in case people couldn't access this information. It specifically talks about renal transplants in these paragraphs:
"A number of studies have demonstrated excellent outcomes in HIV-infected patients who undergo renal transplant. In one of the latest prospective studies performed in the HAART era, patient and allograft outcomes were reported among 18 kidney transplant recipients at a median follow-up of 3.4 years. Patient and allograft survival was 94 and 83 percent; these results are similar to that observed in the general kidney transplant population. One of the findings in the most current studies of renal transplantation in HIV-infected individuals has been the high frequency of rejection that frequently required the use of thymoglobulin. These individuals have had a remarkable and prolonged decrease in CD4 cell counts, which fortunately has not yet been associated with opportunistic infections." (Tebas, 2009)
"Preliminary results from multiple retrospective and some prospective studies show that clinical outcomes do not significantly differ between HIV-infected transplant recipients and HIV-seronegative patients enlisted in the UNOS database in the short term; the one-year survival rates appear comparable between the two groups." (Tebas, 2009)
This article also goes on to speak about other transplants such as heart and liver with some what similar results to the renal transplantation. Even though these surgeries are happening it is not without its problems. Medications that these individuals have to be on after their transplant so their body does reject the organ can have a strong reaction to the antiretrovirals for HIV and because of this it is very important to make sure that the medicine regimen is being monitored as closely as possible (Tebas, 2009).
Works Cited:
Tebas, P. (2009). Solid Organ Transplantation in HIV-infected Individuals. Retrieved from http://www.utdol.com/online/content/topic.do?topicKey=renltran/20766
Wednesday, October 14, 2009
A quiet week
Wednesday, October 7, 2009
Quite an experience

DID YOU KNOW?
Different variants of the HIV virus eventually lead to resistances in known or trusted methods of controlling the virus and its progression. These variants are sometimes due to the HIV reverse transcriptase making errors when it is trying to replcate itself, and it is known that the trascriptase itself is actually prone to these errors (Demeter, 2009). When these errors occur, mutation can become prevalent which leads to the medication becoming resisted (Demeter, 2009). Some of the mutations that HIV undergoes does not copy itself as well as other typical forms but they are said to exist in very small numbers even before the drug therapy is started and this can be a danger because all it sometimes takes for HIV to become resistant to a medicine is one mutation (Demeter, 2009). When you realize the nature of the this disease it starts to become very apparent just why we have not reached an established vaccine or a "cure".
Works Cited:
Demeter, L. M. (2009). Drug resistance testing in the clinical management of HIV infection. Retrieved October 6, 2009 from http://www.utdol.com/online/
Wednesday, September 30, 2009
The waiting game (insert Jeopardy music here).....

View HIV medications by brand name.
|
ddI(Didanosine, Videx)
The Basics | News |Research
Delavirdine(Rescriptor)
The Basics | News |Research
Efavirenz(Sustiva, Stocrin)
The Basics | News |Research
Epzicom(Abacavir/3TC, Kivexa)
Etravirine(Intelence, TMC125)
The Basics | News |Research
Fosamprenavir(Lexiva, Telzir)
The Basics |Research
FTC(Emtricitabine, Emtriva)
The Basics |Research
Indinavir(Crixivan)
The Basics | News |Research
Kaletra(Lopinavir/Ritonavir)
The Basics | News |Research
Maraviroc(Selzentry, Celsentri)
The Basics | News |Research
Source: http://www.thebody.com/content/art40488.html
Wednesday, September 23, 2009
Three's company....


| COST PER MONTH (estimates) - Medication Fact Sheets | |
| Agenerase | $772 |
| Aptivus | $1117.50 |
| Combivir - Buy Here For Less | $752.64 |
| Crixivan | $570.96 |
| Emtriva | $347.11 |
| Epivir 300mg | $347.11 |
| Epzicom | $813.55 |
| Fortovase | $263.35 |
| Fuzeon | $2315.40 |
| Hivid | $273.00 |
| Invirase | $748.50 |
| Kaletra | $796.26 |
| Lexiva | $658.99 |
| Norvir | $321.46 |
| Rescriptor | $316.35 |
| Retrovir | $405.59 |
| Reyataz | $892.91 |
| Sustiva 600mg | $499.43 |
| Trizivir | $1164.35 |
| Truvada | $867.99 |
| Videx EC 400mg | $346.04 |
| Viramune | $442.45 |
| Zerit | $385.88 |
| Ziagen | $466.44 |
Wednesday, September 16, 2009
Statistics




















